Eu. Walther et al., THERAPY FOR MULTIPLE-SCLEROSIS WITH INTER FERON-BETA-1B - ADVICE TO PATIENTS, INCLUDING HOW TO DEAL WITH SIDE-EFFECTS, Nervenarzt, 67(6), 1996, pp. 452-456
Interferon beta-1b has been shown to reduce the frequency and severity
of exacerbations in relapsing-remitting multiple sclerosis (MS). Unre
alistic expectations of the patient and unexpected side effects may le
ad to discontinuation of the drug. Here we provide guidelines how to i
nform the patient adequately before most interferon therapy.